Back
Actinium Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
35
ATNM
Actinium Pharmaceuticals
Last Price:
1.75
Seasonality Move:
-1.83%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Actinium Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Sell |
| 20-day SMA: | 1.74 | Buy |
| 50-day SMA: | 1.81 | Sell |
| 200-day SMA: | 5.72 | Sell |
| 8-day EMA: | 1.77 | Sell |
| 20-day EMA: | 1.78 | Sell |
| 50-day EMA: | 2.25 | Sell |
| 200-day EMA: | 4.74 | Sell |
Actinium Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.65 | Sell |
| Chaikin Money Flow: | 158788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.68 - 1.84) | Sell |
| Bollinger Bands (100): | (1.21 - 6.51) | Sell |
Actinium Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Actinium Pharmaceuticals Stock
Is Actinium Pharmaceuticals Stock a Buy?
- Actinium Pharmaceuticals share price is 1.76 while ATNM 8-day simple moving average is 1.77, which is a Sell signal.
- The stock price of ATNM is 1.76 while Actinium Pharmaceuticals 20-day SMA is 1.74, which makes it a Buy.
- Actinium Pharmaceuticals 50-day simple moving average is 1.81 while ATNM share price is 1.76, making it a Sell technically.
- ATNM stock price is 1.76 and Actinium Pharmaceuticals 200-day simple moving average is 5.72, creating a Sell signal.
ATNM Technical Analysis vs Fundamental Analysis
Sell
35
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a Sell
The current Actinium Pharmaceuticals [ATNM] share price is $1.76. The Score for ATNM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Actinium Pharmaceuticals Stock Info
Market Cap:
54.83M
Price in USD:
1.76
Share Volume:
158.79K
Actinium Pharmaceuticals 52-Week Range
52-Week High:
10.24
52-Week Low:
1.33
Sell
35
Actinium Pharmaceuticals (ATNM)
is a Sell
Actinium Pharmaceuticals Share Price Forecast
-
What is the Actinium Pharmaceuticals stock price today?
The Actinium Pharmaceuticals stock price is 1.76 USD today. -
Will ATNM stock go up or go down?
Actinium Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Actinium Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals is overvalued.
Is Actinium Pharmaceuticals Stock a Buy?
- Actinium Pharmaceuticals share price is 1.76 while ATNM 8-day exponential moving average is 1.77, which is a Sell signal.
- The stock price of ATNM is 1.76 while Actinium Pharmaceuticals 20-day EMA is 1.78, which makes it a Sell.
- Actinium Pharmaceuticals 50-day exponential moving average is 2.25 while ATNM share price is 1.76, making it a Sell technically.
- ATNM stock price is 1.76 and Actinium Pharmaceuticals 200-day simple moving average is 4.74, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals
Is Actinium Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.66 per share.
Technical Analysis of Actinium Pharmaceuticals
Should I short Actinium Pharmaceuticals stock?
- ATNM Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Actinium Pharmaceuticals is a Sell
- Actinium Pharmaceuticals Relative Strength Index (RSI) is 46.65, which suggest Actinium Pharmaceuticals is oversold
- The Bollinger Bands (25) for Actinium Pharmaceuticals is (1.68 - 1.84), which suggest Actinium Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Actinium Pharmaceuticals is (1.21 - 6.51), which suggest Actinium Pharmaceuticals is a Sell
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.